May 06, 2019
A Pennsylvania federal judge questioned Monday whether United Healthcare should have reserved its right to bring in new experts in a looming pay-to-delay trial over the narcolepsy drug Provigil after previously agreeing to use a slate of experts offered up by co-litigants who have since settled their claims.